Concentrix (NASDAQ:CNXC) Releases Q1 2026 Earnings Guidance

Concentrix (NASDAQ:CNXC) updated its first quarter 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 2.570-2.690 for the period. The company issued revenue guidance of $2.5 billion-$2.5 billion. Concentrix also updated its FY 2026 guidance to 11.480-12.070 EPS.

Concentrix Stock Down 13.8%

CNXC opened at $37.97 on Tuesday. Concentrix has a twelve month low of $31.63 and a twelve month high of $66.00. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 1.10. The stock has a market capitalization of $2.36 billion, a price-to-earnings ratio of 8.56, a PEG ratio of 0.59 and a beta of 0.48. The firm has a 50 day moving average price of $38.43 and a 200-day moving average price of $46.77.

Concentrix (NASDAQ:CNXC) last issued its quarterly earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.93 by $0.02. The company had revenue of $2.55 billion for the quarter, compared to analysts’ expectations of $2.54 billion. Concentrix had a return on equity of 16.02% and a net margin of 3.25%.The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period last year, the firm earned $3.26 EPS. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. Equities research analysts forecast that Concentrix will post 10.11 earnings per share for the current year.

Analyst Ratings Changes

CNXC has been the topic of a number of analyst reports. Robert W. Baird lowered their price target on Concentrix from $75.00 to $62.00 and set an “outperform” rating on the stock in a research report on Monday, September 29th. Barrington Research reaffirmed an “outperform” rating and issued a $62.00 target price on shares of Concentrix in a research note on Monday. Weiss Ratings upgraded shares of Concentrix from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday. Canaccord Genuity Group reissued a “buy” rating and issued a $80.00 target price on shares of Concentrix in a research report on Tuesday, September 23rd. Finally, Wall Street Zen upgraded Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, October 25th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $66.25.

Insider Activity

In related news, CEO Christopher A. Caldwell acquired 2,000 shares of Concentrix stock in a transaction on Thursday, October 30th. The shares were acquired at an average cost of $42.03 per share, with a total value of $84,060.00. Following the transaction, the chief executive officer owned 286,661 shares in the company, valued at $12,048,361.83. This trade represents a 0.70% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 3.20% of the company’s stock.

Key Headlines Impacting Concentrix

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Barrington Research reaffirmed an “outperform” rating and set a $62.00 price target, signaling analyst conviction that shares have upside from current levels. Read More.
• Neutral Sentiment: Concentrix reported fiscal Q4 and full-year 2025 results; the release is driving today’s market action as investors parse revenue, margins and management commentary for forward guidance. Read More.
• Neutral Sentiment: Pre-earnings previews and valuation looks have been published, giving investors context on expectations and multiples ahead of the print; these pieces discuss whether recent share moves and valuation are warranted. Read More.
• Neutral Sentiment: Coverage pieces and earnings previews outline key items to watch (revenue growth, margin trends, contract mix and guidance), which can amplify volatility as the market digests results. Read More.
• Neutral Sentiment: Reported short-interest data in the feed is anomalous (shows zero shares), so it does not appear to be a meaningful driver of today’s move based on the available figures.
• Negative Sentiment: Analysts and articles flag concern that while Concentrix has previously beaten guidance, expected revenue growth is slowing — investors often punish stocks when earnings beats are accompanied by weaker growth outlooks. Read More.
• Negative Sentiment: Commentary questioning whether current pricing reflects Concentrix’s multi‑year share decline and changing fundamentals may reinforce selling pressure until there’s clearer guidance or an earnings rebound. Read More.

Institutional Investors Weigh In On Concentrix

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CNXC. Larson Financial Group LLC boosted its position in shares of Concentrix by 224.9% during the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after acquiring an additional 479 shares during the last quarter. Geneos Wealth Management Inc. lifted its stake in shares of Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after purchasing an additional 522 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Concentrix during the 3rd quarter valued at $69,000. Osaic Holdings Inc. raised its position in shares of Concentrix by 13.4% in the 2nd quarter. Osaic Holdings Inc. now owns 2,222 shares of the company’s stock valued at $118,000 after purchasing an additional 263 shares during the last quarter. Finally, Federated Hermes Inc. grew its stake in Concentrix by 81.6% during the 2nd quarter. Federated Hermes Inc. now owns 4,294 shares of the company’s stock valued at $227,000 after purchasing an additional 1,930 shares during the last quarter. 90.34% of the stock is owned by hedge funds and other institutional investors.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.